Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 18, 2012Cancer Biotherapy and Radiopharmaceuticals

Gene Therapy of Malignant Solid Tumors by Targeting erbB2 Receptors and by Activating T Cells

View Full Paper
Ask AI
Bookmark
Share

Authors

WHWangxiong HuHCHeping ChenKYKang Yu

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Hu et al. (2012) studied this question.

synapsesocial.com/papers/6a11081bcd70b138bf1a0cdehttps://doi.org/10.1089/cbr.2012.1246
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1A Phase I Study on Adoptive Immunotherapy Using Gene-Modified T Cells for Ovarian Cancer2006 · 1,258 citations
  2. 2Barnase as a New Therapeutic Agent Triggering Apoptosis in Human Cancer Cells2008 · 83 citations
  3. 3T-cell clones can be rendered specific for CD19: toward the selective augmentation of the graft-versus-B–lineage leukemia effect2003 · 248 citations
  4. 4Antibody-dependent cellular cytotoxicity (ADCC) is mediated by genetically modified antigen-specific human T lymphocytes2006 · 98 citations
  5. 5High efficient mammalian expression and secretion of a functional humanized single-chain Fv/human interleukin-2 molecules2006 · 4 citations